GeneMachines is developing instrumentation for the genomics and proteomics markets including a suite of products facilitating the extraction, replication, isolation, and purification of cDNA. GeneMachines provides solutions for the automation and instrumentation needs of the genomics community. In March /2003, GeneMachines was acquired by Genomic Solutions (Nasdaq:GNSL), itself a subsidiary of Harvard Bioscience